Core Insights - Guorui Life has signed a share transfer agreement to acquire 78.2898% of Chunyu Doctor for a total price of 269 million RMB, becoming its controlling shareholder and officially entering the digital healthcare sector [1][3] - Chunyu Doctor is one of the early internet healthcare service providers in China, with a service network covering over 300 cities and cumulative user services exceeding 400 million, offering a comprehensive service system that includes online consultation, AI diagnosis, offline treatment, and health management [1][3] Strategic Acquisition - The strategic acquisition by Guorui Life is based on a deep insight into the golden track of digital healthcare, seizing opportunities from policy promotion, market evolution, and model restructuring in the healthcare industry [3] - Chunyu Doctor's mature industrial system, scarce medical resources, and validated business closed loop serve as the core support for Guorui Life's strategic transformation, marking the company's formal entry into the digital healthcare space and its move towards becoming an "industry value co-creator" [3] Market Potential - The layout in the high-growth digital healthcare sector will open up vast market space and greater valuation imagination for Guorui Life [3] - The stable business growth, clear technological medical attributes, and predictable profit prospects brought by Chunyu Doctor will reshape the overall competitiveness and valuation logic of Guorui Life, providing strong new momentum and creating long-term returns for all shareholders [3]

Core Viewpoint - Guorui Life (00108) has announced a non-binding letter of intent regarding the potential acquisition of 100% equity in a target company primarily engaged in digital healthcare services, with a transaction value of approximately RMB 269 million (around HKD 294.8 million) [1] Group 1: Acquisition Details - The acquisition involves a conditional agreement between the Chinese operating entity and the seller, with the target company, Beijing Chunyu Tianxia Software, having an issued share capital of approximately 78.3% [1] - The payment will be made through the issuance of 147 million consideration shares at an issue price of HKD 1.6 per share, subject to certain conditions [1] - Four agreements were established on December 5, 2025, including a share purchase agreement, cash purchase agreement, Class A subscription agreement, and Class B subscription agreement [1] Group 2: Target Company Overview - The target group operates "Chunyu Doctor," a leading mobile internet healthcare platform in China, providing online medical consultations, health management, and digital marketing solutions for pharmaceutical and healthcare companies [2] - As of June 2025, the platform has approximately 180 million registered users and 690,000 contracted physicians, processing around 330,000 health consultations daily [2] - The business model benefits from regulatory licenses, providing a counter-cyclical revenue source and complementing the existing real estate-related business of the company [2] Group 3: Strategic Integration - The company aims to leverage its existing resources and market position to assist the target group in expanding its service offerings and user base [3] - The company plans to retain the existing management team of the target group while bringing in industry experts to support the operation and management of digital healthcare services [3] - The integration strategy focuses on maintaining operational knowledge while combining additional expertise and resources to support long-term growth [3] Group 4: Financial Considerations - The company is negotiating with the remaining shareholders of the target company, who collectively hold approximately 12.76% of the equity, to establish a separate purchase agreement [4] - The acquisition price is determined based on the target group's financials, valuation, market position, growth prospects, and expected synergies [4] - Digital healthcare services typically offer recurring service fees and platform revenue, which can enhance revenue visibility and overall gross margin compared to more cyclical development income [4]

智通财经APP讯，国锐生活(00108)发布公告，内容有关本公司与卖方就本集团可能收购潜在标的(主要 从事数字医疗服务)的100%股权订立不具法律约束力的意向书。董事局欣然宣布，于2025年12月5日， 本公司并表附属实体中国经营实体(作为买方)与卖方订立该等协议，中国经营实体有条件同意购买而卖 方有条件同意出售销售股份(目标公司北京春雨天下软件已发行股本总额约78.3%)，代价约为人民币2.69 亿元(相当于约2.948亿港元)，将透过按发行价每股代价股份1.6港元发行及配发1.47亿股代价股份偿付， 惟须符合先决条件。 为维持建议收购事项完成后目标集团现有业务规模并进一步扩展，本公司拟保留目标集团现有管理团 队，并聘请行业专家及专业人士协助目标集团数字医疗服务业务的运营及管理。董事局相信，保留目标 集团现有运营知识，同时引入额外专业知识并结合本集团资源，将有助实现顺利整合，并支持目标集团 的长期增长。 为配合本集团战略及最大化协同价值，本公司正与目标公司两名剩余股东("剩余股东")进行磋商，该等 股东合共持有目标公司约12.76%股权("剩余股份")。本公司与剩余股东已表示有意就剩余股份订立单独 买卖协议 ...

Core Insights - Guorui Life has signed a share transfer agreement with Chunyu Doctor to acquire 78.2898% equity for a total price of 269 million RMB, marking its entry into the digital healthcare sector [1][2] - Chunyu Doctor is one of the early players in China's internet healthcare services, with a service network covering over 300 cities and cumulative user services exceeding 400 million [1][2] Company Strategy - The strategic acquisition is based on a deep understanding of the digital healthcare sector, seizing opportunities from policy support, market evolution, and business model restructuring [2][3] - Chunyu Doctor's established industry system, scarce medical resources, and validated business model serve as the core support for Guorui Life's strategic transformation [2][3] Market Potential - Entering the high-growth digital healthcare sector will open up vast market opportunities and enhance valuation prospects for Guorui Life [2][3] - The acquisition is expected to provide stable business growth, clear technological healthcare attributes, and predictable profit outlook, thereby reshaping the company's overall competitiveness and valuation logic [2][3]

为配合集团战略及最大化协同价值，公司正与目标公司两名剩余股东("剩余股东")进行磋商，该等股东 合共持有目标公司约12.76%股权。公司与剩余股东已表示有意就剩余股份订立单独买卖协议，其条款 及条件将与股份买卖协议及╱或现金买卖协议(如适用)基本一致。公司将根据上市规则适时或按规定作 出进一步公布，以告知股东。 从财务角度看，数字医疗服务通常具有经常性服务费及平台收入特性，长远而言相较更具周期性的开发 收入可提升集团收入可见度及整体毛利水平。 目标集团通过具备正规牌照的医疗机构经营增值电信服务(包括互联网信息服务)及互联网医院╱在线诊 断与治疗服务。此商业模式属规模化，受益于相关监管牌照(包括ICP许可证及《医疗机构执业许可 证》)，预计可提供反周期收入来源，与集团现有房地产相关业务形成互补。集团通过进入高增长行 业，寻求降低传统房地产周期带来的集中风险，提升整体业务韧性。 目标集团在中国数字医疗服务领域拥有稳固客户基础及丰富经验，而公司于中国已建立成熟的客户群、 资源及网络(包括物业管理平台及社区覆盖)。公司拟利用现有资源、市场地位及关系，协助目标集团扩 展服务范围、吸纳新用户及企业客户，从而进一步扩大目标 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 佈 全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 GR LIFE STYLE COMPANY LIMITED 國銳生活有限公司 （於 香 港 註 冊 成 立 之 有 限 公 司） （股 份 代 號：108） 有 關 建 議 收 購 目 標 公 司 銷 售 股 份；及 認 購 或 涉及根據特別授權發行代價股份的 須予披露交易 財務顧問 建議收購事項 茲 提 述 自 願 公 佈，內 容 有 關 本 公 司 與 賣 方 就 本 集 團 可 能 收 購 潛 在 標 的（主 要 從 事 數 字 醫 療 服 務）的100%股 權 訂 立 不 具 法 律 約 束 力 的 意 向 書。董 事 局 欣 然 宣 佈，於 二 零 二 五 年 十 二 月 五 日（交 易 時 段 後），本 公 司 併 表 附 屬 實 體 中 國 經 營實體（作 為 買 方）與 賣 方 訂 立 該 等 協 議，據 此，中 國 經 營 實 體 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年11月30日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 國鋭生活有限公司 | | | 呈交日期: | 2025年12月1日 | | | I. 法定/註冊股本變動 不適用 | | | FF301 第 1 頁 共 10 頁 v 1.1.1 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00108 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 3,219,373,986 | | 0 | | 3,219,373,986 | | 增加 / 減少 (-) | | | 0 | | | | ...

Summary of Key Points Core Viewpoint - As of November 26, a total of 39 stocks reached their 52-week highs, with notable performances from Fire Rock Holdings (02975), Crocodile Garments (02977), and Aisuo Holdings (08585) showing significant increases in their high rates [1]. 52-Week Highs - Fire Rock Holdings (02975) achieved a closing price of 0.114 with a peak of 0.231, marking a high rate of 285.00% - Crocodile Garments (02977) closed at 0.085, reaching a high of 0.189, reflecting a high rate of 170.00% - Aisuo Holdings (08585) closed at 0.021, with a peak of 0.040, resulting in a high rate of 110.53% - Other notable stocks include: - Fulltech Electric Group Holdings (01750) with a high rate of 23.64% - Century United Holdings (01959) at 22.05% - Cassava Resources (00841) at 20.19% [1]. 52-Week Lows - The stock with the largest decline was Jia Jin Investment International (00310), which closed at 0.141, reaching a low of 0.137, resulting in a decline rate of -25.95% - Crown Central Properties (00193) closed at 0.168, with a low of 0.141, reflecting a decline rate of -18.02% - Lion Holdings (02562) had a closing price of 4.710, with a low of 4.680, showing a decline rate of -9.48% - Other significant declines include: - Huading Holdings (03398) at -7.14% - XL Two South Strategy - U (09799) at -5.96% [2].

Core Viewpoint - Guorui Life (00108) has announced a loan agreement with Dalian Bank, where the borrower, Beijing Zhonghe Hongrun Technology Co., Ltd., will receive a loan of RMB 130 million at an annual interest rate of 4.0% for one year, starting from November 11, 2025 [1][2] Group 1 - The loan agreement includes a guarantee and mortgage contract, where the company's indirect wholly-owned subsidiary, Beijing Wankangtong, will assume joint liability for the borrower's repayment obligations [1][2] - The borrower has a broad upstream and downstream customer base, which can recommend high-quality tenants to the company and enter into lease agreements [1][2] - The loan is intended to support the borrower's daily business operations and working capital needs, with the same loan amount and purpose as the previous year's agreement [2] Group 2 - The guarantee fee of 1% per year on the actual amount drawn is considered fair and reasonable, aligning with market rates, and will provide additional income for the company [2] - The properties involved in the mortgage include various units within a building, totaling approximately 12,000 square meters [2]

Group 1 - The company, Guorui Life, announced a loan agreement with Dalian Bank for a principal amount of RMB 130 million, with a one-year term and an interest rate of 4.0% [1] - The loan is secured by a guarantee and mortgage contract, with the company's indirect wholly-owned subsidiary, Beijing Wankangtong, assuming joint liability for the borrower's repayment obligations [1][2] - The borrower, Beijing Zhonghe Hongrun Technology Co., Ltd., applied for the loan to support its daily operations and working capital needs, and the loan term has been extended by one year compared to a previous agreement [2] Group 2 - The guarantee fee charged to the borrower is set at 1% of the actual amount drawn per year, which is considered fair and in line with market rates, providing an additional income source for the company [2] - The properties involved in the mortgage include various units within a building, totaling approximately 12,000 square meters in area [2]